Maria I Van Rompay1, Nicola M McKeown2, Elizabeth Goodman3, Misha Eliasziw4, Virginia R Chomitz4, Catherine M Gordon5, Christina D Economos6, Jennifer M Sacheck6. 1. Friedman School of Nutrition Science and Policy, maria.vanrompay@tufts.edu. 2. Nutritional Epidemiology Program, Jean Mayer USDA Human Nutrition Research Center on Aging, and. 3. MassGeneral Hospital for Children, Boston, MA; Harvard Medical School, Boston, MA; and. 4. Department of Public Health and Community Medicine, School of Medicine, Tufts University, Boston, MA; 5. Divisions of Adolescent Medicine and Endocrinology, Hasbro Children's Hospital, Alpert Medical School of Brown University, Providence, RI. 6. Friedman School of Nutrition Science and Policy.
Abstract
BACKGROUND: Intake of sugar-sweetened beverages (SSBs) is linked to greater cardiometabolic risk in adults. Although longitudinal evidence is sparse among children, SSB intake reduction is targeted to reduce cardiometabolic risk factors in this group. OBJECTIVE: We investigated characteristics associated with consumption of SSBs in a multi-ethnic sample of children/adolescents and measured cross-sectional and longitudinal associations between SSB intake and plasma HDL cholesterol and triglycerides (TGs) over 12 mo. METHODS: In a diverse cohort of children aged 8-15 y, cross-sectional associations (n = 613) between baseline SSB intake and blood lipid concentrations and longitudinal associations (n = 380) between mean SSB intake, changes in SSB intake, and lipid changes over 12 mo were assessed with multivariable linear regression. RESULTS: Greater SSB intake was associated with lower socioeconomic status, higher total energy intake, lower fruit/vegetable intake, and more sedentary time. In cross-sectional analysis, greater SSB intake was associated with higher plasma TG concentrations among consumers (62.4, 65.3, and 71.6 mg/dL in children who consumed >0 but <2, ≥2 but <7, and ≥7 servings/wk, respectively; P-trend: 0.03); plasma HDL cholesterol showed no cross-sectional association. In the longitudinal analysis, mean SSB intake over 12 mo was not associated with lipid changes; however, the 12-mo increase in plasma HDL-cholesterol concentration was greater among children who decreased their intake by ≥1 serving/wk (4.6 ± 0.8 mg/dL) compared with children whose intake stayed the same (2.0 ± 0.8 mg/dL) or increased (1.5 ± 0.8 mg/dL; P = 0.02). CONCLUSIONS: In a multi-ethnic sample of children, intake of SSBs was positively associated with TG concentrations among consumers, and changes in SSB intake were inversely associated with HDL cholesterol concentration changes over 12 mo. Further research in large diverse samples of children is needed to study the public health implications of reducing SSB intake among children of different racial/ethnic groups. The Daily D Health Study was registered at clinicaltrials.gov as NCT01537809.
BACKGROUND: Intake of sugar-sweetened beverages (SSBs) is linked to greater cardiometabolic risk in adults. Although longitudinal evidence is sparse among children, SSB intake reduction is targeted to reduce cardiometabolic risk factors in this group. OBJECTIVE: We investigated characteristics associated with consumption of SSBs in a multi-ethnic sample of children/adolescents and measured cross-sectional and longitudinal associations between SSB intake and plasma HDL cholesterol and triglycerides (TGs) over 12 mo. METHODS: In a diverse cohort of children aged 8-15 y, cross-sectional associations (n = 613) between baseline SSB intake and blood lipid concentrations and longitudinal associations (n = 380) between mean SSB intake, changes in SSB intake, and lipid changes over 12 mo were assessed with multivariable linear regression. RESULTS: Greater SSB intake was associated with lower socioeconomic status, higher total energy intake, lower fruit/vegetable intake, and more sedentary time. In cross-sectional analysis, greater SSB intake was associated with higher plasma TG concentrations among consumers (62.4, 65.3, and 71.6 mg/dL in children who consumed >0 but <2, ≥2 but <7, and ≥7 servings/wk, respectively; P-trend: 0.03); plasma HDL cholesterol showed no cross-sectional association. In the longitudinal analysis, mean SSB intake over 12 mo was not associated with lipid changes; however, the 12-mo increase in plasma HDL-cholesterol concentration was greater among children who decreased their intake by ≥1 serving/wk (4.6 ± 0.8 mg/dL) compared with children whose intake stayed the same (2.0 ± 0.8 mg/dL) or increased (1.5 ± 0.8 mg/dL; P = 0.02). CONCLUSIONS: In a multi-ethnic sample of children, intake of SSBs was positively associated with TG concentrations among consumers, and changes in SSB intake were inversely associated with HDL cholesterol concentration changes over 12 mo. Further research in large diverse samples of children is needed to study the public health implications of reducing SSB intake among children of different racial/ethnic groups. The Daily D Health Study was registered at clinicaltrials.gov as NCT01537809.
Authors: H R Rockett; M Breitenbach; A L Frazier; J Witschi; A M Wolf; A E Field; G A Colditz Journal: Prev Med Date: 1997 Nov-Dec Impact factor: 4.018
Authors: Ravi Dhingra; Lisa Sullivan; Paul F Jacques; Thomas J Wang; Caroline S Fox; James B Meigs; Ralph B D'Agostino; J Michael Gaziano; Ramachandran S Vasan Journal: Circulation Date: 2007-07-23 Impact factor: 29.690
Authors: Sherman J Bigornia; Michael P LaValley; Sabrina E Noel; Lynn L Moore; Andy R Ness; P K Newby Journal: Public Health Nutr Date: 2014-08-28 Impact factor: 4.022
Authors: Nan Jiang; Stella S Yi; Rienna Russo; Daniel D Bu; Donglan Zhang; Bart Ferket; Fang Fang Zhang; José A Pagán; Y Claire Wang; Yan Li Journal: Prev Med Rep Date: 2020-07-10
Authors: Caroline L Miller; Joanne Dono; Melanie A Wakefield; Simone Pettigrew; John Coveney; David Roder; Sarah J Durkin; Gary Wittert; Jane Martin; Kerry A Ettridge Journal: BMJ Open Date: 2019-06-27 Impact factor: 2.692
Authors: Danielle E Haslam; Gina M Peloso; Mark A Herman; Josée Dupuis; Alice H Lichtenstein; Caren E Smith; Nicola M McKeown Journal: J Am Heart Assoc Date: 2020-02-26 Impact factor: 5.501